These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 24057326)

  • 1. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
    Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST
    J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas.
    Cruz GR; Dias Oliveira I; Moraes L; Del Giudice Paniago M; de Seixas Alves MT; Capellano AM; Saba-Silva N; Cavalheiro S; Cerutti JM; Toledo SR
    J Neurooncol; 2014 Apr; 117(2):235-42. PubMed ID: 24532263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel GIT2-BRAF fusion in pilocytic astrocytoma.
    Helgager J; Lidov HG; Mahadevan NR; Kieran MW; Ligon KL; Alexandrescu S
    Diagn Pathol; 2017 Nov; 12(1):82. PubMed ID: 29141672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern.
    Ida CM; Lambert SR; Rodriguez FJ; Voss JS; Mc Cann BE; Seys AR; Halling KC; Collins VP; Giannini C
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):631-9. PubMed ID: 22710963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].
    Pan Y; Qi XL; Wang LM; Dong RF; Zhang M; Zheng DF; Chang Q; Zhong YF
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):292-8. PubMed ID: 24004584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
    Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
    J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
    Antonelli M; Buttarelli FR; Arcella A; Nobusawa S; Donofrio V; Oghaki H; Giangaspero F
    J Neurooncol; 2010 Sep; 99(2):209-15. PubMed ID: 20174854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.
    Suzuki Y; Takahashi-Fujigasaki J; Akasaki Y; Matsushima S; Mori R; Karagiozov K; Joki T; Ikeuchi S; Ikegami M; Manome Y; Murayama Y
    Brain Tumor Pathol; 2016 Jan; 33(1):40-9. PubMed ID: 26445861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of KIAA1549::BRAF fusions and clinicopathological insights of pilocytic astrocytomas.
    Dandapath I; Das S; Charan BD; Garg A; Suri A; Kedia S; Sharma MC; Sarkar C; Khonglah Y; Ahmed S; Suri V
    Ann Diagn Pathol; 2024 Oct; 72():152318. PubMed ID: 38733671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases].
    Xu H; Niu HL; Wang FH; Xu XK; Wang W; Yuan L; Chen K; Gao Q; Li LP; Xia JQ; Guo ZM
    Zhonghua Bing Li Xue Za Zhi; 2024 Sep; 53(9):922-928. PubMed ID: 39231745
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
    Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
    J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
    Jain S; Gupta P; Shankar KB; Singh R; Siraj F
    J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults.
    Badiali M; Gleize V; Paris S; Moi L; Elhouadani S; Arcella A; Morace R; Antonelli M; Buttarelli FR; Figarella-Branger D; Kim YH; Ohgaki H; Mokhtari K; Sanson M; Giangaspero F
    Brain Pathol; 2012 Nov; 22(6):841-7. PubMed ID: 22591444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
    Dono A; Vu J; Anapolsky M; Hines G; Takayasu T; Yan Y; Tandon N; Zhu JJ; Bhattacharjee MB; Esquenazi Y; Ballester LY
    J Neurooncol; 2020 Sep; 149(3):463-472. PubMed ID: 33009979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.
    Yamada S; Kipp BR; Voss JS; Giannini C; Raghunathan A
    Am J Surg Pathol; 2016 Feb; 40(2):279-84. PubMed ID: 26414224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.